Brevan Howard Capital Management LP Sells 96,806 Shares of Halozyme Therapeutics, Inc. $HALO
Brevan Howard Capital Management LP decreased its holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO - Free Report) by 60.1% during the third quarter, according to the company in its most recent...